Medicinal Products: Brigatinib

INN name:

Brigatinib

Lab codes:

AP-26113

Chemical name:

2-[(5-chloro-2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}pyrimidin-4-yl)amino]phenyl}dimethyl-λ⁵-phosphanone

Molecular formula:

C₂₉H₃₉ClN₇O₂P

Chemical Structure:

CAS Registry Number:

1197953-54-0

Originator:

ARIAD Pharmaceuticals

Class:

Antineoplastics

Mechanism of Action:

Tyrosine kinase inhibitor

WHO ATC code:

L01X-E (Protein kinase inhibitors)

EPhMRA code:

L1H (Protein Kinase Inhibitor Antineoplastics)

Clinical Trials:

Indication	Phase	Status
Non-small Cell Lung Cancer	Phase 2	Recruiting
Advanced Malignancies; Carcinoma, Non-Small-Cell Lung; Anaplastic Large Cell Lymphoma; Diffuse Large Cell Lymphoma; Inflammatory Myofibroblastic Tumors	Phase 1 / Phase 2	Active, not recruiting

Product Patent Expiry:

For patent data contact us at drugpatentexpiry@gmail.com

Medicinal Products